U.S. Physical Therapy, Inc.
USPH
$61.96
-$0.43-0.69%
NYSE
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 7.71% | 13.31% | 17.85% | 17.06% | 16.42% |
| Total Other Revenue | 8.70% | 8.77% | 14.61% | 23.19% | 27.00% |
| Total Revenue | 7.88% | 12.54% | 17.28% | 18.05% | 18.11% |
| Cost of Revenue | 8.85% | 11.60% | 17.86% | 16.77% | 19.29% |
| Gross Profit | 4.06% | 15.97% | 15.26% | 22.24% | 13.68% |
| SG&A Expenses | 12.49% | 16.40% | 21.06% | 22.65% | 15.34% |
| Depreciation & Amortization | 2.13% | -22.51% | 32.15% | 33.54% | 42.60% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 8.99% | 10.90% | 18.57% | 17.85% | 19.54% |
| Operating Income | -4.33% | 27.94% | 6.81% | 19.55% | 4.29% |
| Income Before Tax | -39.04% | -18.37% | 85.43% | 53.11% | 17.43% |
| Income Tax Expenses | -37.64% | -0.79% | 104.49% | 60.01% | 22.97% |
| Earnings from Continuing Operations | -39.44% | -26.56% | 80.44% | 51.30% | 15.93% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 12.64% | -54.52% | -43.03% | -26.65% | 0.06% |
| Net Income | -49.11% | -55.07% | 98.22% | 65.11% | 23.03% |
| EBIT | -4.33% | 27.94% | 6.81% | 19.55% | 4.29% |
| EBITDA | -2.48% | 16.41% | 11.89% | 22.22% | 12.90% |
| EPS Basic | -115.26% | -182.45% | 23.61% | 24.12% | 71.58% |
| Normalized Basic EPS | 4.53% | 13.37% | -23.40% | 4.27% | -16.96% |
| EPS Diluted | -115.26% | -182.45% | 23.61% | 24.12% | 71.58% |
| Normalized Diluted EPS | 4.53% | 13.37% | -23.40% | 4.27% | -16.96% |
| Average Basic Shares Outstanding | 0.23% | 0.52% | 0.84% | 0.83% | 0.77% |
| Average Diluted Shares Outstanding | 0.23% | 0.52% | 0.84% | 0.83% | 0.77% |
| Dividend Per Share | 2.22% | 2.27% | 2.27% | 2.27% | 2.27% |
| Payout Ratio | -- | 1.29% | -0.48% | -0.38% | -- |